ASTELLAS PHARMA INC (ALPMF:OTCMKTS)

$15.35 1.1 (7.7193%)

watchlist-icon
search-icon
Profile Icon

Most Recent Average Sentiment Analysis Score (0 to 100): 63

negative-sentiment
Negative [0, 35)
neutral-sentiment
Neutral [35, 65]
positive-sentiment
Positive (65, 100]
Visualize Sentiment Trendline

Analysed ASTELLAS PHARMA INC (ALPMF:OTCMKTS) News Sources

Japan Regenerative Medicine Market Trends and Forecasts to 2035 Featuring Astellas Pharma, Fujifilm, JCR Pharmaceuticals, Sumitomo Pharma, Takeda, and Terumo

13-05-2026

yahoo.com

Australia Regenerative Medicine Market Research Trends and Forecasts Report 2026-2035 Featuring Prominent Players Such as Abbott Laboratories, Astellas Pharma, and Roche

13-05-2026

yahoo.com

Are Medical Stocks Lagging Astellas Pharma (ALPMY) This Year?

13-05-2026

yahoo.com

Astellas to Present Data on Long-Term Outcomes and Clinical Use of Its Portfolio Across Disease Stages at ASCO 2026

18-05-2026

yahoo.com

Hepatic Cirrhosis Market Research and Forecast Report 2026-2036, Profiles of Abbott, Astellas Pharma, Gilead Sciences, Novartis, Takeda Pharma, Grifols Therapeutics, and Cellaion

18-05-2026

yahoo.com

Hepatic Impairment Market Analysis Report 2026-2036 Featuring AbbVie, Astellas Pharma, Gilead Sciences, F. Hoffmann La Roche, and Takeda Pharmaceuticals

21-05-2026

yahoo.com

Merck Stock Climbs on Cancer Data. Why the Drugmaker Is More Than a One-Trick Pony.

22-05-2026

yahoo.com

MRK Stock Gains After CHMP Backs Keytruda Combo for Bladder Cancer

25-05-2026

yahoo.com

Astellas Announces Five-Year Corporate Strategic Plan to Deliver Greater VALUE Faster for Patients and Position Itself as a Sustainable Growth Company

26-05-2026

yahoo.com

Astellas eyes more cost cuts; FDA panel to debate Moderna vaccine

26-05-2026

biopharmadive.com

ASTELLAS PHARMA INC (ALPMF:OTCMKTS) Sentiment Trend

0 25 50 75 100 82 77 5 86 82 91 33 83 88 8 13-05-2026 18-05-2026 21-05-2026 22-05-2026 25-05-2026 26-05-2026 #1 #2 #3 #4 #5 #6 #7 #8 #9 #10 Negative < 35 Neutral 35–65 Positive > 65 View FAQ

ASTELLAS PHARMA INC (ALPMF:OTCMKTS) FAQs

toggle

What is the current price of ASTELLAS PHARMA INC (ALPMF:OTCMKTS)?

The current price of ASTELLAS PHARMA INC (ALPMF:OTCMKTS) is $15.35.


toggle

ASTELLAS PHARMA INC (ALPMF:OTCMKTS) absolute price change since previous trading day?

The absolute price change of ASTELLAS PHARMA INC (ALPMF:OTCMKTS) since the previous trading day is $1.1.


toggle

ASTELLAS PHARMA INC (ALPMF:OTCMKTS) percentage price change since previous trading day?

The percentage price change of ASTELLAS PHARMA INC (ALPMF:OTCMKTS) since the previous trading day is 7.7193%.


toggle

What is the most recent average sentiment score for ASTELLAS PHARMA INC (ALPMF:OTCMKTS)?

The most recent average sentiment score for ASTELLAS PHARMA INC (ALPMF:OTCMKTS) is 63 out of 100.


toggle

What is the most recent average sentiment for ASTELLAS PHARMA INC (ALPMF:OTCMKTS)?

The most recent sentiment for ASTELLAS PHARMA INC (ALPMF:OTCMKTS) is .


SEC-8K** Filing Available For ASTELLAS PHARMA INC (ALPMF:OTCMKTS)

** material developments that could impact a company's financial condition or stock price.

Author: MattELab

X Icon

GitHub Icon

MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.